What It Is
5-Amino-1MQ is frequently marketed and searched for as a "peptide," but that label is chemically inaccurate. The compound, formally 5-amino-1-methylquinolinium, is a small synthetic molecule rather than a chain of amino acids, and it is listed as such in chemical databases like PubChem and the FDA's Global Substance Registration System.[1] It is studied as a selective, membrane-permeable inhibitor of an enzyme called nicotinamide N-methyltransferase, or NNMT.
Because online body-composition and longevity content often lumps metabolic research compounds together with true peptides, 5-Amino-1MQ shows up in peptide-therapy searches despite its distinct chemical class. Common naming variants include 5-Amino-1MQ, 5-amino-1-methylquinolinium, 5-AMQ, and 5A-1MQ, all referring to the same research molecule.
How It Works
NNMT is an enzyme that transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide (a form of vitamin B3). This reaction sits at a crossroads of NAD-related energy metabolism and methylation biology, and NNMT activity varies by tissue, playing different roles in liver, fat, muscle, and cancer cells.[2]
By blocking NNMT, 5-Amino-1MQ is hypothesized to shift this balance in ways that affect fat cell metabolism. In cultured fat cells, NNMT inhibitors lowered 1-methylnicotinamide while raising NAD+ and SAM, and suppressed the pathway that builds new fat. A separate discovery using genetic knockdown of NNMT, rather than the drug itself, found that removing NNMT protected mice from diet-induced obesity, lending plausibility to the target. None of this proves that inhibiting NNMT produces clinical benefit in people.
What the Research Shows
The evidence for 5-Amino-1MQ is almost entirely preclinical. In diet-induced obese mice, the compound reduced body weight, white fat mass, adipocyte size, and cholesterol without changing how much the animals ate. A follow-up study combining the compound with a reduced-calorie diet reported improved body composition and liver fat compared to diet change alone. Separate work in aged mice examined effects on muscle stem cell activity and regeneration, and rat pharmacokinetic studies have characterized how the compound is absorbed and cleared.
No completed human efficacy trials for 5-Amino-1MQ were identified in the scientific and regulatory sources reviewed for this article. Claims about fat loss, longevity, mitochondrial health, or disease treatment in humans remain unproven extrapolations from animal and cell data, and should be read as research hypotheses rather than established outcomes.
Safety & Side Effects
Human safety data for 5-Amino-1MQ are essentially absent. A 2018 mouse study reported no observable adverse effects in that limited setting, but short-term animal observations cannot establish that the compound is safe for people, particularly regarding:
- Liver, kidney, or cardiovascular effects
- Cancer risk, given NNMT's complex and tissue-dependent role in tumor biology
- Pregnancy, breastfeeding, and pediatric use
- Long-term metabolic or hormonal consequences
- Interactions with diabetes, lipid, or weight-loss medications
An absence of reported harm online is not evidence of safety; it more likely reflects a lack of systematic monitoring. Products sold as compounded or research-grade 5-Amino-1MQ carry additional quality risks, since compounded drugs are not reviewed by the FDA for safety, effectiveness, or purity before they reach the market.
Regulatory Status
5-Amino-1MQ is not an FDA-approved drug. No approved label, indication, or dosing information for the compound appears in FDA drug-approval resources such as Drugs@FDA or the Orange Book.[1] It should be treated as an unapproved research chemical rather than a regulated therapeutic, regardless of how it is marketed online.
For compounding pharmacies, FDA rules generally require that a bulk substance either comply with an existing USP/NF monograph, be a component of an already-approved drug product, or appear on FDA's 503A bulk substances list. 5-Amino-1MQ does not have an established path through this framework, which means products labeled as compounded or "research use" 5-Amino-1MQ exist outside standard regulatory oversight.